Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression

Cancer Letters

Volumn 224, Issue 1, 2005, Pages 53-65

  Notarbartolo, Monica ^a   Poma, Paola ^a   Perri, Daniela ^a   Dusonchet, Luisa ^a   Cervello, Melchiorre ^b   D'Alessandro, Natale ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

Author keywords

Cisplatin; Curcumin; Doxorubicin; Hepatocellular carcinoma; Inhibitory of apoptosis proteins; NF kB

Indexed keywords

CASPASE 3; CASPASE 9; CISPLATIN; CURCUMIN; CYCLOOXYGENASE 2; DOXORUBICIN; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CANCER; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CISPLATIN; CURCUMIN; DOXORUBICIN; DRUG INTERACTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; NF-KAPPA B; PROTEINS; TUMOR CELLS, CULTURED;

INTRACISTERNAL A-PARTICLES;

EID: 19344367506     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.10.051     Document Type: Article

References (40)

1. G. Falkson, J.M. MacIntyre, and C.G. Moertel Primary liver cancer Cancer 54 1994 977 980
2. T. Ito, K. Shiraki, K. Sugimoto, T. Yamanaka, K. Fujikawa, and M. Ito Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 2000 1080 1085
3. T. Takehara, X. Liu, J. Fujimoto, S.L. Friedman, and H. Takahashi Expression and role of Bcl-xL in human hepatocellular carcinomas Hepatology 34 2001 55 61
4. M. Ikeguchi, Y. Hirooka, and N. Kaibara Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma Cancer 95 2002 1938 1945
5. K. Shiraki, K. Sugimoto, Y. Yamanaka, Y. Yamaguchi, Y. Saitou, and K. Ito Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma Int. J. Mol. Med. 12 2003 705 708
6. M. Notarbartolo, M. Cervello, L. Giannitrapani, M. Meli, P. Poma, and L. Dusonchet Expression of the IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells Ann. NY Acad. Sci. 1028 2004 289 293
7. Q.L. Deveraux, and J.C. Reed IAP family proteins-suppressors of apoptosis Genes Dev. 13 1999 239 252
8. D. Vucic, H.R. Stennicke, M.T. Pisabarro, G.S. Salvesen, and V.M. Dixit ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas Curr. Biol. 10 2000 1359 1366
9. G.M. Kasof, and B.C. Gomes Livin, a novel inhibitor-of-apoptosis (IAP) family member J. Biol. Chem. 266 2001 3238 3246
10. Y. Suzuki, Y. Nakabayashi, and R. Takahashi Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death Proc. Natl Acad. Sci. USA 98 2001 8662 8667
11. M. MacFarlane, W. Merrison, S.B. Bratton, and G.M. Cohen Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro J. Biol. Chem. 277 2002 36611 36616
12. C.Y. Wang, M.W. Mayo, R.G. Korneluk, D.V. Goeddel, and A.S. Baldwin NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 281 1998 1680 1683
13. N. Mitsiades, C.S. Mitsiades, V. Poulaki, D. Chauhan, P.G. Richardson, and T. Hideshima Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications Blood 99 2002 4079 4086
14. P. Liu, E. Kimmoun, A. Legrand, A. Sauvanet, C. Degott, B. Lardeux, and D. Bernuau Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas J. Hepatol. 37 2002 63 71
15. P.J. Chiao, R. Na, J. Niu, G.M. Sclabas, Q. Dong, and S.A. Curley Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells Cancer 95 2002 1696 1705
16. H. Koga, S. Sakisaka, M. Ohishi, T. Kawaguchi, E. Taniguchi, and K. Sasatomi Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation Hepatology 29 1999 688 696
17. A. Abou-Elella, T. Gramlich, C. Fritsch, and T. Gansler c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis Mod. Pathol. 9 1996 95 98
18. M.P. Duyao, A.J. Buckler, and G.E. Sonesheim Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter Proc. Natl Acad. Sci. USA 87 1990 4727 4731
19. L. Sevilla, A. Zaldumbide, P. Pognonec, and K.E. Boulukos Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families Histol. Histopathol. 16 2001 595 601
20. S. Shishodia, P. Potdar, C.G. Gairola, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 Carcinogenesis 24 2003 1269 1279
21. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
22. T.M. Mitchell Lett. Cancer Res. 63 2003 5165 5166
23. M.C. Berenbaum What is synergy? Pharmacol. Rev. 41 1989 93 141
24. C.Y. Wang, M.W. Mayo, and A.S. Baldwin TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB Science (Washington DC) 274 1996 784 787
25. WAF1/CIP1 and C/EBPβ expressions and suppressing NF-kB activation Prostate 51 2002 211 218
26. S.E. Chuang, P.Y. Yeh, Y.S. Lu, G.M. Lai, C.M. Liao, M. Gao, and A.L. Cheng Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kB (NF-kB), and its attenuation by tamoxifen, dexamethasone and curcumin in carcinoma cells Biochem. Pharmacol. 63 2002 1709 1716
27. K. Ashikawa, S. Shishodia, I. Fokt, W. Priebe, and B.B. Aggarwal Evidence that activation of nuclear factor-kB is essential for the cytotoxic effects of doxorubicin and its analogues Biochem. Pharmacol. 67 2004 353 364
28. S. Somasundaram, N.A. Edmund, D.T. Moore, G.W. Small, Y.Y. Shi, and R.Z. Orlowski Dietary curcumin inhibits chemotherapy-induced apoptosis in model of human breast cancer Cancer Res. 62 2002 3868 3875
29. L and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 24 2003 1199 1208
30. J.H. Bush, K.J.J. Cheung, and G. Li Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53 Exp. Cell Res. 271 2001 301 314
31. A. Bielak-Zmijewska, K. Piwocka, A. Magalska, and E. Sikora P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells Cancer Chemother. Pharmacol. 53 2004 179 185
32. M.M. Chan, D. Fong, K.J. Soprano, W.F. Holmes, and H. Heverling Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents J. Cell Physiol. 194 2003 63 70
33. A. Goel, C.R. Boland, and D.P. Chauhan Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells Cancer Lett. 172 2001 111 118
34. A. Mukhopadhyay, C. Bueso-Ramos, D. Chatterjee, P. Pantazis, and B.B. Aggarwal Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines Oncogene 20 2001 7597 7609
35. J. Li, Q. Feng, J.M. Kim, D. Schneiderman, P. Liston, and M. Li Human ovarian cancer and cisplatin resistance: possible role of apoptosis proteins Endocrinology 142 2001 370 380
36. T. Matsumiya, T. Imaizumi, H. Yoshida, H. Kimura, and K. Satoh Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis in an oral carcinoma cell line Oral Oncol. 37 2001 296 300
37. M. Notarbartolo, M. Cervello, L. Dusonchet, A. Cusimano, and N. D'Alessandro Resistance to diverse apoptotic triggers in multidrug resistant HL-60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (Inhibitory of Apoptosis Proteins) Cancer Lett. 180 2002 91 101
38. M. Zhou, L. Gu, F. Li, Y. Zu, W.G. Woods, and H.W. Findley DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells J. Pharmacol. Exp. Ther. 303 2002 124 131
39. Y. Hu, M. Bally, W.H. Dragowska, and L. Mayer Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis Mol. Cancer Ther. 2 2003 641 649
40. K.J. Campbell, S. Rocha, and N.D. Perkins Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B Mol. Cell 13 2004 853 865